$Quoin Pharmaceuticals (QNRX.US)$ eyes on the spread retail this is how they hold us down buy the real price and hold strong we need to push back above $1 and hold it to gain compliance. we got a winner here if we hold together ❤️
3
6
Report
browny_440
OP
:
give the darkpools nothing don't allow them to send your order into the dark without reflecting the price
browny_440
:
them bots in the chat don't like you and I what sooks bunch of poofters they can't handle a couple of bad weeks. but price target of $2 won't take to long to gain compliance then
Smokey The Bear
OP
browny_440
:
let my haters pile up. I LOVE IT . People will always blame others. rather than looking in the mirror. $2.00 here we come 🫡
$Quoin Pharmaceuticals (QNRX.US)$ Quoin Pharmaceuticals Ltd. (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announced highly positive clinical data from its ongoing Investigator Pediatric Netherton Syndrome (NS) study. Dramatic improvement was observed in the patient’s disease state with clear visual evidence of skin healing observed after just two weeks of whole-body application of QRX003. Both key clinic...
$Quoin Pharmaceuticals (QNRX.US)$ Congratulations to trader who got in for a small profit. Trader with strategy will be easier to trade on momemtum stock. Daily momemtum stock to spot. Follow me , follow momemtum
Quoin Pharmaceuticals Stock Forum
Can Quoin's New Rapamycin Patents Transform Treatment for These Orphan Diseases?
eyes on the spread retail this is how they hold us down buy the real price and hold strong we need to push back above $1 and hold it to gain compliance.
we got a winner here if we hold together ❤️
just keep holding still early days. all year long if we have to I'll never sell at a loss
Quoin Pharmaceuticals Ltd. (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announced highly positive clinical data from its ongoing Investigator Pediatric Netherton Syndrome (NS) study. Dramatic improvement was observed in the patient’s disease state with clear visual evidence of skin healing observed after just two weeks of whole-body application of QRX003.
Both key clinic...
Congratulations to trader who got in for a small profit.
Trader with strategy will be easier to trade on momemtum stock.
Daily momemtum stock to spot.
Follow me , follow momemtum
No comment yet